|
Volumn 30, Issue 8, 1998, Pages 4001-4004
|
Adverse effects of immunosuppressive drugs on long-term graft outcome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
RAPAMYCIN;
TACROLIMUS;
TRANSFORMING GROWTH FACTOR BETA;
ATHEROSCLEROSIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOMEGALOVIRUS INFECTION;
DRUG INDUCED DISEASE;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEPHROTOXICITY;
ORGAN TRANSPLANTATION;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
ANIMALS;
CYTOMEGALOVIRUS INFECTIONS;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMANS;
HYPERLIPIDEMIAS;
HYPERTENSION;
IMMUNOSUPPRESSIVE AGENTS;
TIME FACTORS;
TRANSPLANTATION IMMUNOLOGY;
TREATMENT OUTCOME;
|
EID: 0032440509
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01319-0 Document Type: Conference Paper |
Times cited : (17)
|
References (62)
|